Skip to main content
Figure 5 | BMC Endocrine Disorders

Figure 5

From: Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas

Figure 5

Correlation of serum CgA levels with insulinoma size, primary location and age of patients with insulinomas. Figure 5 A The serum levels of CgA did not correlate with insulinoma size (n = 56). Individual CgA levels are presented as dots. Figure 5 B The serum levels of CgA in elder patients with insulinomas were significantly higher than that in younger patients (n = 57). The ends of the error bars represent the minimum and maximum of CgA levels in different groups. Figure 5 C The serum levels of CgA were significantly associated with primary location of insulinomas (P = 0.009).

Back to article page